Limited Competition of the MAPP Research Network(U01)

The summary for the Limited Competition of the MAPP Research Network(U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Limited Competition of the MAPP Research Network(U01): The Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network conducts multi-center studies of urologic chronic pelvic pain syndromes (UCPPS) commonly known as interstitial cystitis/bladder pain syndrome (IC/BPS) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). The goal of the MAPP Network is to provide new insights into underlying etiology, natural history, and risk factors in order to provide a translational foundation to facilitate future clinical intervention efforts and improve clinical management for the syndromes. The MAPP Research Network is currently comprised of six Discovery Sites, a Data Coordination Core (DCC), and a Tissue and Technology Core (TATC). In the second project period, the MAPP Research Network will continue analyses of clinical data and assays of biological samples collected in the first project period and develop and implement a second phase of collaborative protocols. Another goal will be to generate a resource of clinical data and biological samples for sharing with the community in support of future studies designed to further advance discovery in this area. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications from the current MAPP Discovery and Core Sites for a second five year project period through a Limited Competition.

Federal Grant Title:	Limited Competition of the MAPP Research Network(U01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Food and Nutrition Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-DK-13-507
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.313, 93.847
CFDA Descriptions:	NIH Office of Research on Women's Health; Diabetes, Digestive, and Kidney Diseases Extramural Research
Current Application Deadline:	Nov 27, 2013
Original Application Deadline:	Nov 27, 2013
Posted Date:	Aug 22, 2013
Creation Date:	Aug 23, 2013
Archive Date:	Dec 28, 2013
Total Program Funding:	$7,000,000
Maximum Federal Grant Award:	none
Minimum Federal Grant Award:	none
Expected Number of Awards:	6
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Private institutions of higher education
State governments
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Special district governments
Native American tribal governments (Federally recognized)
Native American tribal organizations (other than Federally recognized tribal governments)
City or township governments
Independent school districts
Small businesses
County governments
Public housing authorities/Indian housing authorities
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Public and State controlled institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-13-507.html
Grant Announcement Contact: NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
Similar Government Grants: • Impact of Comorbidities and Co-Infections on HIV Reservoirs (R01 Clinical Trial Not Allowe...; • R25 for Short Courses on Techniques for Measuring Intimate Partner Violence (IPV) in Diffe...; • Career Enhancement Award to Advance the Study of Intimate Partner Violence (IPV) in the Co...; • Firearm Injury Prevention in Community Healthcare Settings (R01 Clinical Trial Optional); • Immune Mechanisms at the Maternal-Fetal Interface (R01 Clinical Trial Not Allowed); • Prevention of Lower Urinary Tract Symptoms in Women: Bladder Health Scientific and Data Co...; • Prevention of Lower Urinary Tract Symptoms in Women: Bladder Health Clinical Centers (PLUS...; • Pelvic Floor Disorders Network Data Coordinating Center (U24)
More Grants from the National Institutes of Health: • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...; • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...; • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional); • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...